Global Transdermal Drug Delivery Market Trends and Drivers, Restraints, and Opportunities 2017-2023


A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intrapatient variations. Microneedles and thermal ablation are currently progressing through clinical trials for delivery of macromolecules and vaccines, such as insulin, parathyroid hormone and influenza vaccine. Using these novel second- and third-generation enhancement strategies, transdermal delivery is poised to significantly increase impact on medicine.

Transdermal drug delivery has made an important contribution to medical practice, but has yet to fully achieve its potential as an alternative to oral delivery and hypodermic injections. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The market in the North America is driven by rise in the demand of innovative drug delivery market in this region and growing acceptance of drug delivery technology by pharmaceutical and medical device companies. The European transdermal drug delivery market will grow at a healthy rate over the forecasted period owing to the increasing demand for self-administration and home healthcare devices. Asia pacific market is projected to grow at a substantial rate owing to a steep rise in medical tourism in the region, world-class medical facilities and medical procedures at a low cost, rising incidents of chronic diseases like cardiovascular diseases, diabetes, cancer etc. Few of the prominent players in the market are Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Acrux Ltd., Echo Therapeutics Inc., and Endo Pharmaceuticals Inc.

The report provides the complete details of various market trends and adoption rate in various segments and across the regions. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the Transdermal Drug Delivery market.

This report also provides the competitive landscape of the leading players in Global Transdermal Drug Delivery market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.

Report Scope:

  • Healthcare Category
    • PHARMACEUTICALS
  • Type by Application
    • Hormonal Diseases
    • Pain Management
    • Central Nervous System Disorders
    • Cardiovascular Disease
    • Others
  • Regions
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities

Request for TOC at sales@infoholicresearch.com

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Secondary & Primary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

methodology

Market related information is congregated from both secondary and primary sources. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

For more details on Research Methodology kindly click here to Engage with our Analyst.


Category :


Pages

Tables

Charts

Regions/countries

/

Companies


Enquiry Hours

10